CONMED (CNMD) vs Tandem Diabetes Care (TNDM)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Tandem Diabetes Care (TNDM) has outperformed CONMED (CNMD) over the past year, gaining 2.2% versus a loss of 3.0%. Over five years, CNMD leads with a -68.2% price change compared with -87.5% for TNDM. CONMED is the larger company by market cap ($1.35 billion vs $1.09 billion), about 1.2 times the size.
On valuation, CONMED trades at a lower forward P/E (9.4x vs 98.6x for Tandem Diabetes Care). CONMED pays a dividend yielding 0.44%, while Tandem Diabetes Care does not currently pay one.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CNMD | TNDM |
|---|---|---|
| Share price | $45.11 | $15.68 |
| Market cap | $1.35B | $1.09B |
| 1-day change | +1.99% | -1.04% |
| YTD return | +11.11% | -28.69% |
| 1-year return | -3.03% | +2.18% |
| 5-year return | -68.24% | -87.50% |
| P/E ratio (TTM) | 24.38 | — |
| Forward P/E | 9.43 | 98.61 |
| EPS (TTM) | $1.85 | $-0.91 |
| Dividend yield | 0.44% | 0.00% |
| Annual dividend | $0.20 | $0.00 |
| 52-week high | $53.66 | $29.65 |
| 52-week low | $31.44 | $12.26 |
| Distance from 52-week high | -15.93% | -47.13% |
| Analyst consensus | none | buy |
| Avg. price target upside | +0.86% | +77.74% |
| Average volume | 482.58K | 2.01M |
| Shares outstanding | 29.95M | 69.58M |
| Employees | 3,900 | 2,500 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Medical/Dental Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About CONMED
CNMD stock →CONMED Corporation, a medical technology company, develops, manufactures, and sells devices and equipment for surgical procedures. The company offers orthopedic surgery products, including BioBrace, TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-knot All-Suture Anchors, and Agro Knotless Suture Anchors, which provide clinical solutions to orthopedic surgeons for the augmentation and repair of soft tissue injuries, as well as supporting products include powered resection instruments , fluid management, and visualization systems and the related single-use products that enable surgeons to perform minimally invasive sports medicine surgeries.
Health Care · Biotechnology: Electromedical & Electrotherapeutic Apparatus · 3,900 employees
About Tandem Diabetes Care
TNDM stock →Tandem Diabetes Care, Inc. designs, develops, and commercializes technology solutions for people living with diabetes in the United States and internationally.
Health Care · Medical/Dental Instruments · 2,500 employees
CNMD vs TNDM FAQ
Which is bigger, CONMED or Tandem Diabetes Care?
CONMED (CNMD) is larger, with a market capitalization of $1.35B compared with $1.09B for Tandem Diabetes Care (TNDM).
Which stock has performed better over the past year, CNMD or TNDM?
TNDM returned +2.18% over the past 12 months, compared with -3.03% for CNMD (price return, excluding dividends). Past performance does not predict future results.
Which pays a higher dividend, CONMED or Tandem Diabetes Care?
CONMED pays a dividend yielding 0.44%, while Tandem Diabetes Care does not currently pay a regular dividend.
Are CONMED and Tandem Diabetes Care in the same industry?
Both are in the Health Care sector, but in different industries: Biotechnology: Electromedical & Electrotherapeutic Apparatus for CONMED and Medical/Dental Instruments for Tandem Diabetes Care.